Cargando…
BLT2, a leukotriene B(4) receptor 2, as a novel prognostic biomarker of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is considered to be a notorious type of cancer due to its aggressive metastatic potential and poor prognosis. Recent evidence suggests that BLT2, a low-affinity LTB(4) receptor is critically associated with the phenotypes of TNBC cells, including invasion, metast...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Biochemistry and Molecular Biology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130834/ https://www.ncbi.nlm.nih.gov/pubmed/29898809 http://dx.doi.org/10.5483/BMBRep.2018.51.8.127 |